Already some publicity from the Fool...
The Alterity Therapeutics Ltd (ASX: ATH) share price has rocketed an incredible 1,841% to 33 cents. Investors have been scrambling to buy the biotech company’s shares after it revealed that its meeting with the U.S. FDA has provided it with a development pathway for its ATH434 candidate. ATH434 is the company’s lead compound for the treatment of Multiple System Atrophy (MSA), a Parkinsonian disorder.
Day trading goes against everthing I was taught about investing. But you know what they say, if you can't beat em...
Ann: Response to ASX Price Query, page-74
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $18.13K | 6.046M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 83 | 102964005 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 153111101 | 60 |
View Market Depth
| Last trade - 15.59pm 13/11/2024 (20 minute delay) ? |
| ATH (ASX) Chart |